Danaher Corporation (BIT:1DHR)

Market Cap	126.18B
Revenue (ttm)	20.50B
Net Income (ttm)	2.91B
Shares Out	n/a
EPS (ttm)	4.02
PE Ratio	43.32
Forward PE	25.03
Dividend	0.78 (0.46%)
Ex-Dividend Date	Jun 26, 2025

Volume	n/a
Average Volume	25
Open	168.04
Previous Close	168.04
Day's Range	168.04 - 168.04
52-Week Range	159.04 - 261.90
Beta	n/a
RSI	41.71
Earnings Date	Jul 22, 2025

About Allakos

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manuf...

• Industry: Laboratory Analytical Instruments
• Founded: 1969
• Employees: 63,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1DHR

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.